$2500 | Single User
$5000 | Site License
$7500 | Enterprise License

Hypercholesterolemia Global Clinical Trials Review, H2, 2017
[Report Updated: 27-09-2017]

Published by Global Data: 27 Sep 2017 | 138425 | In Stock
Related Topics: Clinical Trials , Hypercholesterolemia

Introduction

Hypercholesterolemia Global Clinical Trials Review, H2, 2017

Summary

GlobalData's clinical trial report, “Hypercholesterolemia Global Clinical Trials Review, H2, 2017" provides an overview of Hypercholesterolemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hypercholesterolemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Hypercholesterolemia Global Clinical Trials Review, H2, 2017 [Report Updated: 27-09-2017]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    GlobalData Clinical Trials Report Coverage 6

    Clinical Trials by Region 7

    Clinical Trials and Average Enrollment by Country 8

    Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

    Top Five Countries Contributing to Clinical Trials in Europe 11

    Top Countries Contributing to Clinical Trials in North America 12

    Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

    Top Five Countries Contributing to Clinical Trials in Central and South America 14

    Clinical Trials by G7 Countries: Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials 15

    Clinical Trials by Phase in G7 Countries 16

    Clinical Trials in G7 Countries by Trial Status 17

    Clinical Trials by E7 Countries: Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials 18

    Clinical Trials by Phase in E7 Countries 19

    Clinical Trials in E7 Countries by Trial Status 20

    Clinical Trials by Phase 21

    In Progress Trials by Phase 22

    Clinical Trials by Trial Status 23

    Clinical Trials by End Point Status 24

    Subjects Recruited Over a Period of Time 25

    Clinical Trials by Sponsor Type 26

    Prominent Sponsors 27

    Top Companies Participating in Hypercholesterolemia Therapeutics Clinical Trials 28

    Prominent Drugs 29

    Latest Clinical Trials News on Hypercholesterolemia 30

    Sep 19, 2017: Gemphire Announces Plans to Advance Gemcabene into Phase 3 Clinical Development 30

    Aug 28, 2017: New, One-Year Data from ORION-1 Phase II Study of Inclisiran Extends Excellent Long-Term Efficacy and Safety Profile, Affirming Dose for Phase III Trials 31

    Aug 25, 2017: Regeneron and Sanofi to Present New Analyses from Praluent Injection Trials at the ESC Congress 2017 32

    Aug 21, 2017: Amgen To Present New Data From The Repatha (Evolocumab) Cardiovascular Outcomes Study At ESC Congress 2017 33

    Aug 16, 2017: Repatha (Evolocumab) Phase 3 Cognitive Function Study Results Published In The New England Journal Of Medicine 34

    Aug 08, 2017: Esperion Announces Positive Top-Line Results From Phase 2 Study of Bempedoic Acid / Ezetimibe Combination Plus Atorvastatin 35

    Aug 07, 2017: Gemphire Announces Top-Line Data from ROYAL-1 Phase 2b Clinical Trial in Hypercholesterolemic Patients 35

    Jul 26, 2017: Esperion Announces Initiation of Phase 2 Study of Bempedoic Acid Added-On to a PCSK9 Inhibitor 36

    Clinical Trial Profile Snapshots 37

    Appendix 768

    Abbreviations 768

    Definitions 768

    Research Methodology 769

    Secondary Research 769

    About GlobalData 770

    Contact Us 770

    Source 770

List Of Tables
in Hypercholesterolemia Global Clinical Trials Review, H2, 2017 [Report Updated: 27-09-2017]

List of Tables

Hypercholesterolemia Therapeutics, Global, Clinical Trials by Region, 2017* 7

Hypercholesterolemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8

Hypercholesterolemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9

Hypercholesterolemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10

Hypercholesterolemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11

Hypercholesterolemia Therapeutics Clinical Trials, North America, Top Countries, 2017* 12

Hypercholesterolemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 13

Hypercholesterolemia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 14

Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials, G7 Countries (%), 2017* 15

Hypercholesterolemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16

Hypercholesterolemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17

Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials, E7 Countries (%), 2017* 18

Hypercholesterolemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19

Hypercholesterolemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20

Hypercholesterolemia Therapeutics, Global, Clinical Trials by Phase, 2017* 21

Hypercholesterolemia Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22

Hypercholesterolemia Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23

Hypercholesterolemia Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24

Hypercholesterolemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25

Hypercholesterolemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26

Hypercholesterolemia Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27

Hypercholesterolemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28

Hypercholesterolemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

List Of Figures, Charts and Diagrams
in Hypercholesterolemia Global Clinical Trials Review, H2, 2017 [Report Updated: 27-09-2017]

List of Figures

Hypercholesterolemia Therapeutics, Global, Clinical Trials by Region (%), 2017* 7

Hypercholesterolemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8

Hypercholesterolemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9

Hypercholesterolemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10

Hypercholesterolemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11

Hypercholesterolemia Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12

Hypercholesterolemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 13

Hypercholesterolemia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 14

Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials, G7 Countries (%), 2017* 15

Hypercholesterolemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16

Hypercholesterolemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17

Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials, E7 Countries (%), 2017* 18

Hypercholesterolemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19

Hypercholesterolemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20

Hypercholesterolemia Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21

Hypercholesterolemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22

Hypercholesterolemia Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23

Hypercholesterolemia Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24

Hypercholesterolemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25

Hypercholesterolemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26

Hypercholesterolemia Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27

Hypercholesterolemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28

Hypercholesterolemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

GlobalData Methodology 769

Additional Details

Publisher

Global Data

Publisher Information

Reference

138425 | GDHC4610CTIDB

Number of Pages

770

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Heterozygous familial hypercholesterolemia (heFH) - Pipeline Review, H2 2016
Heterozygous familial hypercholesterolemia (heFH) - Pipeline Review, H2 2016SummaryGlobal Markets Di...
30 Nov 2016 by Global Markets Direct USD $2,000 More Info
Hypercholesterolemia - Pipeline Review, H2 2016
Hypercholesterolemia - Pipeline Review, H2 2016SummaryGlobal Markets Direct's latest Pharmaceutical ...
23 Nov 2016 by Global Markets Direct USD $2,000 More Info
Global Hypercholesterolemia Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,495 More Info
Global Hypercholesterolemia Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2016
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2016...
30 Jun 2016 by Global Data USD $2,500 More Info
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2016
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2016...
30 Jun 2016 by Global Data USD $2,500 More Info
Hypercholesterolemia Global Clinical Trials Review, H1, 2016
Hypercholesterolemia Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial repor...
31 May 2016 by Global Data USD $2,500 More Info
Hypercholesterolemia Global Clinical Trials Review, H1, 2016
Hypercholesterolemia Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial repor...
31 May 2016 by Global Data USD $2,500 More Info
Heterozygous familial hypercholesterolemia (heFH) Global Clinical Trials Review, H2, 2015
Heterozygous familial hypercholesterolemia (heFH) Global Clinical Trials Review, H2, 2015SummaryGlob...
23 Dec 2015 by Global Data USD $2,500 More Info
Homozygous Familial Hypercholesterolemia (HoFH) Global Clinical Trials Review, H2, 2015
Homozygous Familial Hypercholesterolemia (HoFH) Global Clinical Trials Review, H2, 2015SummaryGlobal...
23 Dec 2015 by Global Data USD $2,500 More Info

This report is published by Global Data

Download Free Report Summary PDF

Hypercholesterolemia Global Clinical Trials Review, H2, 2017 [Report Updated: 27-09-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • 360i Research
  • 99Strategy
  • Allied Market Research
  • Asia Market Information & Development Co.
  • Azoth Analytics
  • BioInformant
  • Black Swan Analysis
  • Canadean
  • CBR Pharma Insights
  • CRI
  • Current Analysis
  • Current Partnering
  • Daedal Research
  • Data bridge
  • Delve Insight
  • DPI Research
  • FirstWord Pharma
  • Future Market Insights
  • GBI Research
  • Global Data
  • Global Markets Direct
  • Global Research and Data Services GRDS
  • GMR Data
  • HeyReport
  • HongChun
  • HTStec
  • ICD Research
  • iGATE Research
  • IMARC
  • Industry ARC
  • Inkwood Research
  • IQ4I
  • Jain PharmaBiotech
  • Kelly Scientific
  • La Merie
  • Lifescience Intellipedia
  • LP Information
  • Market Data Forecast
  • Market Research Future
  • Marketline
  • MarketsandMarkets
  • McDerson
  • MedMarket Diligence
  • Meticulous Research
  • MicroMarketMonitor
  • MIReports
  • Mordor Intelligence LLC
  • MP Advisors
  • Occams Business Research
  • Prof Research
  • Progressive Markets
  • ProGrow Pharma Partners
  • Renub
  • Research Impact
  • RNCOS
  • Rockville Research
  • S&P Consulting
  • StratisticsMRC
  • The Business Research Company
  • Triton Market Research
  • Venture Planning Group (VPG)